CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like Arbor Biotechnologies
Arbor Biotechnologies logo

Arbor Biotechnologies

arbor.bio
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative genomic medicines using a proprietary toolbox of novel gene editors tailored to each disease's pathology.
DHLLCSLAJMTDDMML
201651-200 emp
20 Acorn Park Dr, Cambridge, Massachusetts
$50 Million to 100 Million revenue
Biotechnology Research
NAICS 541714
1813•••••00
TECH STACK
ZendeskApache HTTP ServerCloudflareContact Form 7Google AnalyticsGoogle Tag ManagerMonsterInsightsMySQLPHPWordPressWordPress Super CacheYoast SEO
Arbor Biotechnologies campaignconsultative3000 target
Companies like Arbor Biotechnologies — Biotechnology Research, 51-200
“Position Arbor as a differentiated gene-editing platform partner offering novel editors and delivery approaches that expand therapeutic possibilities beyond first-generation CRISPR, accelerating internal pipelines for genetic and rare disease programs through co-development, licensing, or discovery collaborations.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 23
Decision-makers 33
Emails 20
Signals 0

Companies like Arbor Biotechnologies — competitors and alternatives

CompanyWhat they doLocationSizeHiring
Arbor Biotechnologiesarbor.bio
JMCYCS
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curativeCambridge, Massachusetts51-200
Editas Medicineeditasmedicine.com
LBGGJX
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipelCambridge, Massachusetts51-200
Intelliatxintelliatx.com
BSNCJM
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severeCambridge, Massachusetts201-1000
CRISPR Therapeuticscrisprtx.com
PPJDEF
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever apprBoston, Massachusetts201-1000
Beam Therapeuticsbeamtx.com
JVGSMA
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a Cambridge, Massachusetts201-1000
Verve Therapeuticsvervetx.com
AKRFYF
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovasBoston, Massachusetts51-200
Sangamo Therapeuticssangamo.com
DESSMC
Sangamo Therapeutics is a biotechnology company developing gene-based therapies using proprietary zinc finger technology, includinBrisbane, California201-1000
Manifold Biomanifold.bio
BDSLAG
Manifold Bio is a platform therapeutics company building the first AI-guided direct-to-vivo discovery platform. Its mDesign engineBoston, Massachusetts51-200
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, oSeattle, Washington1-10
SWJTSM
Verve is a global advertising technology company that connects advertisers to publishers across emerging digital channels — mobileNew York, New York201-1000
Cariboubiosciencescariboubiosciences.com
Caribou Biosciencescariboubio.com
SPTNDS
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using Berkeley, California51-200
Logicbiologicbio.com
REGENXBIOregenxbio.com
AKODSV
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene Rockville, Maryland201-1000
Vervegenevervegene.com
Homologymedicinehomologymedicine.com
Precisionbiosciencesprecisionbiosciences.com
Precision BioSciences (Nasdaq: DTIL) is a clinical-stage gene editing company based in Durham, North Carolina, developing in vivo Durham, North Carolina51-200
Graphite Biographitebio.com
Graphite Bio is a clinical-stage, next-generation gene editing company based in South San Francisco, California, pioneering the UlSouth San Francisco, California1-10
Allogene Therapeuticsallogene.com
Allogene Therapeutics is a clinical-stage biotechnology company developing investigational allogeneic chimeric antigen receptor T South San Francisco, California201-1000
Crisptherapeuticscrisptherapeutics.com
Elysium Healthelysiumhealth.com
Elysium Health is a longevity science company that develops health products from natural compounds, translating advances in sciencNew York, New York51-200
Run live for more

Agent activity

Done
$fetch_profilearbor.bio
Found: Arbor Biotechnologies
$analyze_identityarbor.bio
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative genomic medicines using a proprietary toolbox of
$search_companiescompanies like Arbor Biotechnologies
24 companies
$search_peopledecision-makers

Frequently asked questions about Arbor Biotechnologies

What does Arbor Biotechnologies do?

Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative genomic medicines using a proprietary toolbox of novel gene editors tailored to each disease's pathology.

Who are Arbor Biotechnologies's competitors?

Companies like Arbor Biotechnologies include Editas Medicine, Intelliatx, CRISPR Therapeutics, Beam Therapeutics, Verve Therapeutics. See the full list of 24 competitors and alternatives above.

How many employees does Arbor Biotechnologies have?

Arbor Biotechnologies has approximately 51-200 employees and is in the Biotechnology Research industry.

Where is Arbor Biotechnologies headquartered?

Arbor Biotechnologies is headquartered in Cambridge, Massachusetts.

What industry is Arbor Biotechnologies in?

Arbor Biotechnologies operates in the Biotechnology Research industry.

Who are the decision-makers at Arbor Biotechnologies?

Key decision-makers and buying contacts at Arbor Biotechnologies are listed above, including leaders across executive, finance, sales and operations.